4/3/2012

Marina Biotech Completes Dosing of Second Cohort in the Phase 1b START-FAP Clinical Trial of CEQ508

4/19/2012 

Marina Biotech Regains Intellectual Property Rights to its tkRNAi™ Technology for Agriculture and Veterinary Uses

5/10/2012

Marina Biotech Receives Three Notices of Allowances from the USPTO and an Intent to Grant Notice from the European Patent Office

8/3/2012

Marina Biotech Announces Worldwide Non‐Exclusive Licensing Agreement for Nucleic Acid Chemistry

11/29/2012

Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement with Nucleic Acid Chemistry to Tekmira Pharmaceuticals

Scroll Up